Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Autor: Anderson, Anna, Ang, Mary, Barnes, Timothy, Bassin, Michelle, Bessey, Kate, Bowler, Simon, Bull, Sheetal, Burr, Lucy, Burton, Robert, Byrne, Michelle, Carroll, Robert, Chee, Nicholas, Choy, Aaron, Clark, Malcolm, Dalebout, Marije, De Wet, Peter, Deshmukh, Kshama, Diez Alvarez, Sergio, Douglas, Dominic, Engelander, Jacqueline, Evangelista, Carla, Game, Stuart, Glass, Noor, Gunner, Elizabeth, Han, Jennifer, Harrison, Michael, Hing Kiang, Jason Doong, Hlaing, Thazin, Joshi, Divyansh, Joyce, Sheree, Kaluhin, Karen, Kavic, Milanka, Kononov, Juliana, Lee, Gary, Lee, Wei-I, Leelasena, Indika, Leong, Esmond, Lim, Ivan, Lister, Graham, Loh, Denissa, Magdy, Mary, Maggs, Callum, Mammoottil, Amith, McCarthy, Shannon, McKay, Nicole, Melek, Mariah, Michael Barnett, Adrian, Mohan, Rahul, Moore, Andrew, Moore, Amanda, Murdoch, Louise, Napier-Flood, Fiona, Narsai, Ushma, Neville, Alexander, Nguyen, Paul, Odarchenko, Ekaterina, Pardey, Toni, Quan, Dick, Ranagsinghe, Ushank, Rasalam, Roy, Rayar, Shiva, Ruthnam, Gonasagaran Jay, Seet, Pi, Smith, Deon, Srilakshmanan, Krishna, Taggart, Angela, Tiong, Florence, Toh, Boon, Ujvary, Eniko, Wallace, Stephanie, Wolf, Rebecca, Wong, Ian, Yoo, Hye, Young, Rhys, Bennett, Chijioke ^*, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, McCallum Pardey, Toni G, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M

Publikováno v: In The Lancet Infectious Diseases June 2024 24(6):581-593

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial

Autor: Adams, Mark, Arya, Mark, Athan, Eugene, Berger, Ira, Bradley, Paul, Briskin, Toby, Glover II, Richard, Griffin, Paul, Kim, Joshua, Kitchener, Scott, Klein, Terry, Leah, Amber, Leelasena, Indika, Lemech, Charlotte, Lickliter, Jason, Manning, Mary Beth, Napier-Flood, Fiona, Nugent, Paul, Thackwray, Susan, Turner, Mark, Mallory, Raburn M ^*, Formica, Neil, Pfeiffer, Susan, Wilkinson, Bethanie, Marcheschi, Alex, Albert, Gary, McFall, Heather, Robinson, Michelle, Plested, Joyce S, Zhu, Mingzhu, Cloney-Clark, Shane, Zhou, Bin, Chau, Gordon, Robertson, Andreana, Maciejewski, Sonia, Hammond, Holly L, Baracco, Lauren, Logue, James, Frieman, Matthew B, Smith, Gale, Patel, Nita, Glenn, Gregory M

Publikováno v: In The Lancet Infectious Diseases November 2022 22(11):1565-1576

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetrahydrocannabinol and Cannabidiol for Treatment of Chronic Back or Neck Pain: A Multiple-Dose Escalation Study.

Autor: Glare, Paul, Chye, Richard, Bloch, Mark, Arya, Mark, Moore, Andrew, Montgomery, John

Publikováno v: Medical Cannabis & Cannabinoids; 2023, Vol. 6 Issue 1, p66-76, 11p